France· FR:68337593
ACUILIX 20 mg/12,5 mg, comprimé pelliculé sécable
A medicinal product, registered in France by PFIZER HOLDING FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- PFIZER HOLDING FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400933640798plaquette(s) thermoformée(s) PVC aluminium polyamide de 28 comprimé(s)EUR 3.42
- cip133400937243940plaquette(s) thermoformée(s) PVC aluminium polyamide de 90 comprimé(s)EUR 10.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ACUILIX in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAccupro CompPfizer Oy
- United StatesQuinapril and HydrochlorothiazideChartwell RX, LLC
- United KingdomAccuretic 10mg/12.5mg tabletsSigma Pharmaceuticals Plc
- CanadaAURO-QUINAPRIL HCTZAURO PHARMA INC
- ItalyQUINAPRIL E IDROCLOROTIAZIDE MYLAN GENERICSMYLAN S.P.A.
- SpainBICETIL 20 mg / 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULALaboratorios Menarini S.A.
- GermanyQuinaplusAliud Pharma Gmbh
- SwedenKinoprilam comp 10 mg/12,5 mg Filmdragerad tablettSTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Quinaplus, Quinapril/Hydrochlorothiazid Aurobindo
- Spain · Lidaltrin-Diu
- Italy · Quinapril E Idroclorotiazide Mylan Generics, Quinapril Idroclorotiazide Aurobindo
- Netherlands · Quinapril/Hct Cf
- Sweden · Kinoprilam Comp
- Slovakia · Stadapress
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6efeb89e-385b-4c94-840f-40965aedfb20 GET /v1/drugs/6efeb89e-385b-4c94-840f-40965aedfb20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68337593",
"date_amm": "1993-07-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about ACUILIX.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.